![Annovis Bio](https://i0.wp.com/www.mychesco.com/wp-content/uploads/2020/02/Annovis-Bio.jpg?resize=735%2C400&ssl=1)
Annovis Bio’s Buntanetap Shows Promise in Early Alzheimer’s Disease Study
MALVERN, PA — In a significant development for Alzheimer’s Disease (AD) research, Annovis Bio, Inc. (NYSE: ANVS) has unveiled new data from a study indicating that buntanetap, an innovative oral …
Annovis Bio’s Buntanetap Shows Promise in Early Alzheimer’s Disease Study Read More